Analysts Set BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) PT at $13.63
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Get Free Report) has been given a consensus rating of “Buy” by the seven research firms that are currently covering the stock, Marketbeat Ratings reports. Seven analysts have rated the stock with a buy recommendation. The average twelve-month target price among brokerages that have issued ratings on the stock in […]
More Stories
Tgs Asa (OTCMKTS:TGSNF) Shares Down 2.3% – Here’s What Happened
Tgs Asa (OTCMKTS:TGSNF – Get Free Report)’s stock price dropped 2.3% during trading on Monday . The stock traded as...
Dassault Aviation société anonyme (OTCMKTS:DUAVF) Stock Price Down 1.6% – Time to Sell?
Dassault Aviation société anonyme (OTCMKTS:DUAVF – Get Free Report) was down 1.6% during mid-day trading on Monday . The company...
Amplifon (OTCMKTS:AMFPF) Trading 1.7% Higher – Time to Buy?
Amplifon S.p.A. (OTCMKTS:AMFPF – Get Free Report)’s share price traded up 1.7% on Monday . The stock traded as high...
First National Financial (OTCMKTS:FNLIF) Shares Down 3.4% – Here’s Why
First National Financial Co. (OTCMKTS:FNLIF – Get Free Report)’s stock price dropped 3.4% during mid-day trading on Monday . The...
X Financial (NYSE:XYF) Shares Down 2.4% – Should You Sell?
Shares of X Financial (NYSE:XYF – Get Free Report) traded down 2.4% during trading on Monday . The company traded...
Cohen & Company Inc. (NYSEAMERICAN:COHN) Sees Significant Drop in Short Interest
Cohen & Company Inc. (NYSEAMERICAN:COHN – Get Free Report) was the target of a significant drop in short interest in...